Join NCSD and TCA for a discussion on the rollout of Doxy as STI PEP in the U.S.
NCSD and The Choice Agenda (TCA)
October 5, 2023
As we await official guidance from the Centers for Disease Control and Prevention, please join The Choice Agenda (TCA) and the National Coalition of STD Directors (NCSD) for a U.S.- focused discussion on the roll out of Doxycycline as STI PEP for helping gay, bisexual, and other men who have sex with men and transgender women reduce bacterial STIs, including gonorrhea, chlamydia, and syphilis.
Dr. Taimur Khan, Fenway Health
Cait Shea, NCSD
Kendrick Clack, NP, Crofoot MD Clinic/Research Center Doxy user